Literature DB >> 19812304

mTOR signaling at a glance.

Mathieu Laplante1, David M Sabatini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19812304      PMCID： PMC2758797          DOI： 10.1242/jcs.051011

Source DB:  PubMed          Journal:  J Cell Sci        ISSN： 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  71 in total

1.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 2.  Regulation of mTOR by phosphatidic acid?

Authors:  David A Foster
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin.

Authors:  Todd A Huffman; Isabelle Mothe-Satney; John C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

4.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

5.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

6.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

7.  mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.

Authors:  Christine Mayer; Jian Zhao; Xuejun Yuan; Ingrid Grummt
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

8.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

9.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

10.  Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

Authors:  Andrew R Tee; Brendan D Manning; Philippe P Roux; Lewis C Cantley; John Blenis
Journal:  Curr Biol       Date:  2003-08-05       Impact factor: 10.834
View more
  950 in total

1.  Inhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover.

Authors:  Stephen Bertsch; Charles H Lang; Thomas C Vary
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

Review 2.  Tissue-specific regulation and function of Grb10 during growth and neuronal commitment.

Authors:  Robert N Plasschaert; Marisa S Bartolomei
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 3.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

4.  Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.

Authors:  E Norsted Gregory; S Codeluppi; J A Gregory; J Steinauer; C I Svensson
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

5.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

6.  Primary cilia regulate mTORC1 activity and cell size through Lkb1.

Authors:  Christopher Boehlke; Fruzsina Kotsis; Vishal Patel; Simone Braeg; Henriette Voelker; Saskia Bredt; Theresa Beyer; Heike Janusch; Christoph Hamann; Markus Gödel; Klaus Müller; Martin Herbst; Miriam Hornung; Mara Doerken; Michael Köttgen; Roland Nitschke; Peter Igarashi; Gerd Walz; E Wolfgang Kuehn
Journal:  Nat Cell Biol       Date:  2010-10-24       Impact factor: 28.824

7.  Metabolic adaptation of short-living growth hormone transgenic mice to methionine restriction and supplementation.

Authors:  Holly M Brown-Borg; Sharlene Rakoczy; Joseph A Wonderlich; Kurt E Borg; Lalida Rojanathammanee
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

8.  The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.

Authors:  Minqing Jiang; Rohit Rao; Jincheng Wang; Jiajia Wang; Lingli Xu; Lai Man Wu; Jonah R Chan; Huimin Wang; Q Richard Lu
Journal:  Glia       Date:  2018-05-03       Impact factor: 7.452

9.  Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB.

Authors:  Aaron T Wecksler; Sung Hee Hwang; Hiromi I Wettersten; Jennifer E Gilda; Amy Patton; Leonardo J Leon; Kermit L Carraway; Aldrin V Gomes; Keith Baar; Robert H Weiss; Bruce D Hammock
Journal:  Anticancer Drugs       Date:  2014-04       Impact factor: 2.248

10.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.